In short
This article discusses a clinical trial investigating the use of Tianeptine Sodium, an atypical antidepressant, for treating patients with Treatment Resistant Depression (TRD). The study aims to evaluate the effectiveness of Tianeptine in patients who have not responded to previous antidepressant treatments and to explore its unique mechanism of action involving the opioid system.
At a glance
- Drug Name
- Tianeptine Sodium (Tianeurex)
- Condition Studied
- Treatment Resistant Depression (TRD)
- Dosage
- 12.5 mg, 3 times daily (9am, 1pm, 5pm)
- Treatment Duration
- 8 weeks
- Participant Age Range
- 21-60 years
- Number of Participants
- 75
- Primary Outcome Measure
- Hamilton Rating Scale for Depression (HRSD)
- Additional Assessments
- MRI scans, genomic testing
- Study Locations
- Icahn School of Medicine at Mount Sinai, Stanford University School of Medicine
What is Tianeptine?
Tianeptine Sodium, also known by its brand name Tianeurax, is an atypical antidepressant that has been used clinically in Europe, Asia, and South America since the late 1980s. It's important to note that this medication is not currently available in the United States. Tianeptine is being studied as a potential treatment for Treatment-Resistant Depression (TRD), which occurs when a person with depression doesn't respond to at least two different antidepressant treatments.
How Tianeptine Works
Tianeptine works differently from other antidepressants currently approved in the United States. While most antidepressants affect brain systems that involve chemicals like serotonin, norepinephrine, and dopamine, tianeptine acts on the opioid system in the brain. Specifically, it acts as an agonist (activator) of the mu-opioid receptor (MOR). This means it binds to and activates these receptors in a way similar to the body's natural painkillers, enkephalins and endorphins.
Clinical Trial Overview
A clinical trial is being conducted to study the effectiveness of tianeptine in treating TRD. This study is taking place at two locations in the United States: the Mood and Anxiety Disorders Program at the Icahn School of Medicine at Mount Sinai (MSSM) and the Stanford Depression Research Clinic at Stanford University School of Medicine (SUSM).
Treatment Details
In this study, participants will receive tianeptine treatment for 8 weeks. The medication, Tianeurax 12.5 mg, will be taken three times a day at 9 AM, 1 PM, and 5 PM. This dosing schedule is designed to maintain consistent levels of the medication in the body throughout the day.
Study Procedures
The study involves several procedures to evaluate how tianeptine affects participants:
- Depression Assessment: The main measure of the study is the Hamilton Rating Scale for Depression (HRSD), which helps evaluate the severity of depression symptoms and track improvement over time.
- Brain Imaging: Some participants will undergo MRI scans to examine how tianeptine affects brain activity, particularly in response to social situations and pain.
- Genetic Testing: Blood samples will be taken for genetic analysis to help understand how a person's genes might influence their response to the medication.
Potential Benefits
The researchers hope that tianeptine could offer several potential benefits for people with TRD:
- New Treatment Option: Tianeptine could provide relief for people who haven't responded to other antidepressants.
- Targeting Specific Mechanisms: By focusing on the opioid system, tianeptine might help a specific subgroup of people with depression who have deficits in this system.
- Understanding Depression: This study could help researchers better understand the different biological factors that contribute to depression, potentially leading to more personalized treatments in the future.
Important Considerations
While tianeptine shows promise, it's important to keep in mind:
- Experimental Treatment: Tianeptine is not currently approved for use in the United States and is being studied as an experimental treatment.
- Opioid Action: Because tianeptine acts on opioid receptors, there may be concerns about its potential for dependence or misuse. However, it's important to note that its effects are different from typical opioid drugs.
- Individual Response: As with all medications, the effectiveness and side effects of tianeptine may vary from person to person.